Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples
Articolo
Data di Pubblicazione:
2023
Citazione:
Routine Molecular Profiling in Both Resectable and Unresectable Pancreatic Adenocarcinoma: Relevance of Cytologic Samples / Redegalli, Miriam; Grassini, Greta; Magliacane, Gilda; Pecciarini, Lorenza; Schiavo Lena, Marco; Smart, Chanel E; Johnston, Rebecca L; Waddell, Nicola; Maestro, Roberta; Macchini, Marina; Orsi, Giulia; Petrone, Maria Chiara; Rossi, Gemma; Balzano, Gianpaolo; Falconi, Massimo; Arcidiacono, Paolo G; Reni, Michele; Doglioni, Claudio; Cangi, Maria Giulia. - In: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. - ISSN 1542-3565. - 21:11(2023), pp. 2825-2833. [10.1016/j.cgh.2022.10.014]
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive disease, for which it is crucial to promptly detect actionable and prognostic alterations to drive specific therapeutic decisions, regardless of tumor resectability status. Endoscopic ultrasonography-guided fine-needle aspiration (EUS-FNA) is of key importance for PDAC diagnosis and can contribute significantly to tumor molecular profiling.
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
BRCA; Cytology; EUS-FNA; Molecular Profile; NGS; PDAC; Precision Medicine; Resectable; Unresectable
Elenco autori:
Redegalli, Miriam; Grassini, Greta; Magliacane, Gilda; Pecciarini, Lorenza; Schiavo Lena, Marco; Smart, Chanel E; Johnston, Rebecca L; Waddell, Nicola; Maestro, Roberta; Macchini, Marina; Orsi, Giulia; Petrone, Maria Chiara; Rossi, Gemma; Balzano, Gianpaolo; Falconi, Massimo; Arcidiacono, Paolo G; Reni, Michele; Doglioni, Claudio; Cangi, Maria Giulia
Link alla scheda completa:
Pubblicato in: